Home Reproductive Health Tags

View the Latest: Reproductive Health

Filter

List Grid

101 - 110 of 518 Results

  • Considerations for Covering Over-the-Counter Contraception

    Policy Watch

    In October 2023, the Departments of the Treasury, Labor, and Health and Human Services issued a request for information to gather public input about the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover OTC preventive services and supplies without a prescription. This policy watch addresses key considerations for the implementation of insurance coverage for non-prescribed OTC contraceptives based on the lessons learned from KFF’s 2023 study of Insurance Coverage…

  • KFF Examines How Abortion Bans, Misinformation, and State Actions May Affect Access to Contraception

    News Release

    Following the Supreme Court’s ruling overturning Roe v. Wade, uncertainty has emerged over whether the right to contraception could also be limited. Justice Thomas’ concurring opinion in Dobbs renewed attention and raised the possibility that other Supreme Court precedents relying on the same principles as Roe, such as the right of people to obtain contraceptives, could also be overturned. In response, legislative bodies at the state and federal level have debated, and in some cases…

  • Large Shares of Black Adults, Hispanic Adults, and Rural Residents are Unsure Whether to Believe Many False Health Claims  

    News Release

    Drawing on KFF’s Misinformation Pilot Poll, KFF today released three follow-up reports examining exposure to, and belief in, health misinformation among Black adults, Hispanic adults, and rural communities. As with the general public, large shares within each group are uncertain about whether each of 10 false health claims are true or not, describing them as either “probably true” or “probably false.” This uncertainty leaves people vulnerable to misinformation but also provides an opportunity to combat…

  • KFF Examines Challenges in Navigating Coverage for Opill, the First Over-the-Counter Daily Oral Contraceptive Pill, Coming to Market Next Year 

    News Release

    As Opill—the first over-the-counter daily oral contraceptive pill in the United States—is expected to be available for purchase in early 2024, new research conducted by KFF examines barriers to its accessibility for consumers and challenges in providing insurance coverage for it. Based on interviews with nearly 80 representatives from private insurance plans, state Medicaid programs, chain pharmacies, and other key groups, the report provides a deeper view into the operational challenges in expanding access to…

  • Insurance Coverage of OTC Oral Contraceptives: Lessons from the Field

    Report

    This report is based on 35 structured interviews conducted from January to August 2023, with nearly 80 experts and key players such as pharmacists, health plans, and state Medicaid officials involved in the coverage and provision of OTC contraception in seven states with one or more of these coverage approaches (IL, NJ, NM, NY, OR, UT, and WA). It discusses the challenges and successes in coverage under private health insurance and Medicaid and reviews policy…

  • KFF Health Misinformation Tracking Poll Pilot

    Poll Finding

    The poll reveals that at least four in ten U.S. adults saying they’ve heard each of 10 specific false claims about COVID-19, reproductive health, and gun violence. While relatively small shares definitely believes the false claims, many more are uncertain about them. The survey also examines the public’s social and traditional media use and trust in sources of health information.

  • Poll: Most Americans Encounter Health Misinformation, and Most Aren’t Sure Whether It’s True or False 

    News Release

    A new KFF survey reveals the broad reach of health misinformation, with at least four in 10 people saying that they’ve heard each of 10 specific false claims about COVID-19, reproductive health, and gun violence. Relatively small shares say that each of those false claims are “definitely true”, ranging from as few as 3% who definitively believe that COVID-19 vaccines have been proven to cause infertility to as many as 18% who definitively believe armed…